Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection

Helicobacter pylori (H. pylori), the major cause of several gastric disorders has been recognied as a type I carcinogen. By virtue of resistance developed by H. pylori strains, currently used antibiotic based treatments rather demonstrate high failure rates. Hence, there is an emerging need for iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Juvale, Kapil, Purushothaman, Gayathri, Singh, Vijay, Shaik, Althaf, Ravi, Srimadhavi, Thiruvenkatam, Vijay, Kirubakaran, Sivapriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336804/
https://www.ncbi.nlm.nih.gov/pubmed/30655593
http://dx.doi.org/10.1038/s41598-018-37490-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336804/
https://www.ncbi.nlm.nih.gov/pubmed/30655593
http://dx.doi.org/10.1038/s41598-018-37490-x

Ejemplares similares